A detailed history of Parkside Financial Bank & Trust transactions in Dexcom Inc stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 2,294 shares of DXCM stock, worth $258,052. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,294
Previous 2,086 9.97%
Holding current value
$258,052
Previous $258,000 23.26%
% of portfolio
0.05%
Previous 0.05%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$114.22 - $140.1 $23,757 - $29,140
208 Added 9.97%
2,294 $318,000
Q4 2023

Feb 01, 2024

BUY
$75.49 - $124.16 $16,456 - $27,066
218 Added 11.67%
2,086 $258,000
Q2 2023

Aug 15, 2023

BUY
$112.47 - $130.98 $11,584 - $13,490
103 Added 5.84%
1,868 $240,000
Q1 2023

May 04, 2023

BUY
$104.0 - $122.92 $728 - $860
7 Added 0.4%
1,765 $205,000
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $24,304 - $35,083
286 Added 19.43%
1,758 $199,000
Q3 2022

Nov 01, 2022

SELL
$76.35 - $94.18 $5,268 - $6,498
-69 Reduced 4.48%
1,472 $119,000
Q2 2022

Jul 13, 2022

BUY
$67.99 - $132.89 $94,914 - $185,514
1,396 Added 962.76%
1,541 $114,000
Q1 2022

May 13, 2022

BUY
$94.08 - $130.2 $376 - $520
4 Added 2.84%
145 $74,000
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $3,896 - $4,884
30 Added 27.03%
141 $75,000
Q3 2021

Oct 29, 2021

BUY
$106.71 - $143.18 $4,908 - $6,586
46 Added 70.77%
111 $61,000
Q2 2021

Aug 06, 2021

BUY
$80.99 - $107.93 $3,077 - $4,101
38 Added 140.74%
65 $28,000
Q1 2021

May 10, 2021

BUY
$84.79 - $104.74 $763 - $942
9 Added 50.0%
27 $10,000
Q4 2020

Feb 09, 2021

SELL
$78.0 - $104.5 $6,474 - $8,673
-83 Reduced 82.18%
18 $6,000
Q3 2020

Nov 06, 2020

BUY
$95.51 - $112.95 $95 - $112
1 Added 1.0%
101 $42,000
Q2 2020

Aug 10, 2020

SELL
$62.68 - $105.34 $2,381 - $4,002
-38 Reduced 27.54%
100 $41,000
Q1 2020

May 05, 2020

SELL
$47.79 - $75.63 $2,628 - $4,159
-55 Reduced 28.5%
138 $37,000
Q4 2019

Jan 30, 2020

BUY
$36.62 - $57.29 $695 - $1,088
19 Added 10.92%
193 $42,000
Q3 2019

Nov 05, 2019

BUY
$35.53 - $43.8 $568 - $700
16 Added 10.13%
174 $26,000
Q1 2019

May 01, 2019

SELL
$28.07 - $38.18 $449 - $610
-16 Reduced 9.2%
158 $19,000
Q4 2018

Jan 31, 2019

BUY
$26.99 - $37.37 $431 - $597
16 Added 10.13%
174 $21,000
Q2 2018

Aug 03, 2018

BUY
$17.54 - $25.22 $1,613 - $2,320
92 Added 139.39%
158 $15,000
Q1 2018

May 02, 2018

BUY
$13.06 - $18.54 $861 - $1,223
66 New
66 $5,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $43.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.